病例报告:恶性周血管上皮细胞瘤与侵袭性中枢膜侵袭和肺转移
Daniel F Leach1, Srivikram Margam S2, Marissa Foster3
1Department of Radiation Oncology, The Ohio State University, Columbus, OH, United States.
Frontiers in oncology
|September 3, 2025
概括
恶性周血管上皮细胞瘤 (PEComas) 是罕见的和具有攻击性的. 这种病例突显了中性PEComa对标准疗法的耐药性,强调了需要新的治疗策略.
科学领域:
- 癌症学
- 病理学
- 软组织瘤
背景情况:
- 周血管上皮细胞瘤 (PEComas) 是一种罕见的软组织瘤.
- 恶性PEComa异常罕见,可以表现出侵略性行为,包括转移和局部复发.
- 由于对常规化疗和放射治疗的耐药性,无法切除或转移的PEComa的治疗选择有限.
研究的目的:
- 呈现出一种高度侵袭性的恶性PEComa,并进行肺部移植.
- 突出临床过程和管理这种罕见和激进的PEComa病例的挑战.
- 对无法切除或转移的PEComa进行现有治疗策略的审查.
主要方法:
- 一个59岁的男性病人的详细临床病例介绍.
- 尽管使用西罗和放射治疗进行全身治疗,但疾病进展的记录.
- 对中PEComa和治疗模式的现有文献的审查.
主要成果:
- 患者患有高度侵袭性恶性PEComa, 侵袭了中, 并取代了右侧的中侧和下侧肺叶.
- 这种瘤对全身西洛利和终极放射治疗产生了耐药性.
- 这代表了几例恶性PEComa侵袭中的病例之一.
结论:
- 恶性PEComa可能具有侵略性的局部侵入性和对标准治疗的抵抗性.
- 这是一种极其罕见但极具破坏性的表现.
- 对侵袭性和不可切除的PEComa进行进一步的研究是有必要的.
更多相关视频
07:54Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
7.0K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
相关概念视频
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
